HIGHLIGHTS
- who: Francesca Bonifazi from the Italy Department of Onco-Hematology, Hematology and Bone Marrow Transplantation, Raffaele Scientific Institute, Milan, Vita-Salute Raffaele University have published the paper: Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01, in the Journal: (JOURNAL) of 14/02/2022
- what: For the patients activating the URD search at diagnosis and then becoming resistant/ refractory, the study entry was immediately possible while for those ones not activating the URD search at diagnosis for any . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.